| Title | CNS Drugs |
| Abbreviation | CNS Drugs |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Neurology (clinical) (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1) |
| h-index | 129 |
| Overall Rank/Ranking | 1975 |
| SCImago Journal Rank (SJR) | 1.616 |
| Impact Score | 6.14 |
| Publisher | Adis International Ltd |
| Country | United Kingdom |
| ISSN | 11791934, 11727047 |
| Best Quartile | Q1 |
| Coverage History | 1994-2023 |
CNS Drugs is a one-stop shop for all important information about the drug treatment of psychiatric and neurological disorders. The journal takes a bench to bedside approach, covering topics from basic pharmacology and disease pathology to drugs in development and guidelines for clinical practice.
Each issue of CNS Drugs provides:
* current opinion/leading articles providing an overview of contentious or emerging issues
* definitive reviews on approaches to the management of neurological and psychiatric illnesses
* therapy in practice reviews providing practical recommendations for specific clinical situations
CNS Drugs is a journal covering the technologies/fields/categories related to Neurology (clinical) (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1). It is published by Adis International Ltd. The overall rank of CNS Drugs is 1975. According to SCImago Journal Rank (SJR), this journal is ranked 1.616. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 129. The best quartile for this journal is Q1.
The ISSN of CNS Drugs journal is 11791934, 11727047. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. CNS Drugs is cited by a total of 1631 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of CNS Drugs is 6.14, which is computed in 2024 as per its definition. CNS Drugs IF is increased by a factor of 0.45 and approximate percentage change is 7.91% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of CNS Drugs is 6.14. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 6.14 |
| 2022 | 5.69 |
| 2021 | 5.94 |
| 2020 | 4.66 |
| 2019 | 4.65 |
| 2018 | 4.39 |
| 2017 | 4.61 |
| 2016 | 5.11 |
| 2015 | 5.60 |
| 2014 | 5.77 |
CNS Drugs has an h-index of 129. It means 129 articles of this journal have more than 129 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of CNS Drugs is 11791934, 11727047. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of CNS Drugs is 1975. According to SCImago Journal Rank (SJR), this journal is ranked 1.616. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.616 |
| 2022 | 1.485 |
| 2021 | 1.263 |
| 2020 | 1.565 |
| 2019 | 1.522 |
| 2018 | 1.553 |
| 2017 | 1.635 |
| 2016 | 1.819 |
| 2015 | 1.767 |
| 2014 | 1.922 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1975 |
| 2022 | 2173 |
| 2021 | 2809 |
| 2020 | 2109 |
| 2019 | 2171 |
| 2018 | 2110 |
| 2017 | 1970 |
| 2016 | 1674 |
| 2015 | 1798 |
| 2014 | 1500 |
CNS Drugs is published by Adis International Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1994-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of CNS Drugs is CNS Drugs. This abbreviation ('CNS Drugs') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Neurology (clinical) (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
CNS Drugs latest impact IF is 6.14. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 6.14 (2023) and 4.39 (2018), respectively, in the last 10 years. Moreover, its average IS is 5.26 in the previous 10 years.
The CNS Drugs has an SJR (SCImago Journal Rank) of 1.616, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.922 in 2014 and the lowest being 1.263 in 2021. Furthermore, the average SJR of the CNS Drugs over the previous 10-year period stands at 5.26.
The latest h-index of the CNS Drugs is 129.
The CNS Drugs is published by the Adis International Ltd, with its country of publication being the United Kingdom.
The CNS Drugs is currently ranked 1975 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1500 in 2014 and its lowest position of 2809 in 2021.
The standard ISO4 abbreviation for the CNS Drugs is CNS Drugs.
CNS Drugs is classified as a journal that the Adis International Ltd publishes.
The CNS Drugs encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The CNS Drugs is assigned the following International Standard Serial Numbers (ISSN): 11791934, 11727047.
The best quartile for the CNS Drugs is Q1 (2023).
The CNS Drugs coverage history can be summarized as follows: 1994-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Qualitative Research | journal | 1588 | SAGE Publications Ltd | 93 | 4.87 |
| Journal of International Financial Management and Accounting | journal | 1921 | Wiley-Blackwell Publishing Ltd | 45 | 9.38 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| Child and Family Social Work | journal | 8089 | Wiley-Blackwell Publishing Ltd | 75 | 2.10 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 16153 | Taylor and Francis Ltd. | 25 | 1.10 |
| British Journal of Special Education | journal | 16076 | Wiley-Blackwell Publishing Ltd | 44 | 0.78 |
| Syntax | journal | 3731 | Wiley-Blackwell Publishing Ltd | 33 | 0.93 |
| Transnational Corporations | journal | 11181 | UNCTAD United Nations Conference on Trade and Development | 28 | 1.83 |
| Built Environment | journal | 12809 | Alexandrine Press | 46 | 1.18 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 6.14 |
| 2022 | 5.69 |
| 2021 | 5.94 |
| 2020 | 4.66 |
| 2019 | 4.65 |
| 2018 | 4.39 |
| 2017 | 4.61 |
| 2016 | 5.11 |
| 2015 | 5.60 |
| 2014 | 5.77 |
